617 related articles for article (PubMed ID: 17711303)
1. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
Li JG; Chen C; Liu-Chen LY
Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells.
Li J; Li JG; Chen C; Zhang F; Liu-Chen LY
Mol Pharmacol; 2002 Jan; 61(1):73-84. PubMed ID: 11752208
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of the human kappa opioid receptor by agonists: etorphine and levorphanol reduced dynorphin A- and U50,488H-induced internalization and phosphorylation.
Li JG; Zhang F; Jin XL; Liu-Chen LY
J Pharmacol Exp Ther; 2003 May; 305(2):531-40. PubMed ID: 12606694
[TBL] [Abstract][Full Text] [Related]
4. GEC1 interacts with the kappa opioid receptor and enhances expression of the receptor.
Chen C; Li JG; Chen Y; Huang P; Wang Y; Liu-Chen LY
J Biol Chem; 2006 Mar; 281(12):7983-93. PubMed ID: 16431922
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation.
Li JG; Benovic JL; Liu-Chen LY
Mol Pharmacol; 2000 Oct; 58(4):795-801. PubMed ID: 10999950
[TBL] [Abstract][Full Text] [Related]
6. (-)U50,488H [(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)-cyclohexyl]benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, kappa-opioid receptor: structural basis for the differential regulation.
Zhang F; Li J; Li JG; Liu-Chen LY
J Pharmacol Exp Ther; 2002 Sep; 302(3):1184-92. PubMed ID: 12183679
[TBL] [Abstract][Full Text] [Related]
7. Localization of the kappa opioid receptor in lipid rafts.
Xu W; Yoon SI; Huang P; Wang Y; Chen C; Chong PL; Liu-Chen LY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1295-306. PubMed ID: 16505160
[TBL] [Abstract][Full Text] [Related]
8. Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists.
Chen Y; Chen C; Wang Y; Liu-Chen LY
J Pharmacol Exp Ther; 2006 Nov; 319(2):765-75. PubMed ID: 16882876
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of agonists on adenylyl cyclase superactivation mediated by the kappa opioid receptors: adenylyl cyclase superactivation is independent of agonist-induced phosphorylation, desensitization, internalization, and down-regulation.
Wang Y; Li JG; Huang P; Xu W; Liu-Chen LY
J Pharmacol Exp Ther; 2003 Dec; 307(3):1127-34. PubMed ID: 14557376
[TBL] [Abstract][Full Text] [Related]
10. Agonist-promoted Lys63-linked polyubiquitination of the human kappa-opioid receptor is involved in receptor down-regulation.
Li JG; Haines DS; Liu-Chen LY
Mol Pharmacol; 2008 Apr; 73(4):1319-30. PubMed ID: 18212250
[TBL] [Abstract][Full Text] [Related]
11. Agonist-induced desensitization and down-regulation of the human kappa opioid receptor expressed in Chinese hamster ovary cells.
Zhu J; Luo LY; Mao GF; Ashby B; Liu-Chen LY
J Pharmacol Exp Ther; 1998 Apr; 285(1):28-36. PubMed ID: 9535991
[TBL] [Abstract][Full Text] [Related]
12. Ezrin-radixin-moesin-binding phosphoprotein-50/Na+/H+ exchanger regulatory factor (EBP50/NHERF) blocks U50,488H-induced down-regulation of the human kappa opioid receptor by enhancing its recycling rate.
Li JG; Chen C; Liu-Chen LY
J Biol Chem; 2002 Jul; 277(30):27545-52. PubMed ID: 12004055
[TBL] [Abstract][Full Text] [Related]
13. Agonist-induced regulation and trafficking of kappa opioid receptors.
Liu-Chen LY
Life Sci; 2004 Jun; 75(5):511-36. PubMed ID: 15158363
[TBL] [Abstract][Full Text] [Related]
14. Biosynthesis of the insulin-like growth factor-II (IGF-II)/mannose-6-phosphate receptor in rat C6 glial cells: the role of N-linked glycosylation in binding of IGF-II to the receptor.
Kiess W; Greenstein LA; Lee L; Thomas C; Nissley SP
Mol Endocrinol; 1991 Feb; 5(2):281-91. PubMed ID: 1645456
[TBL] [Abstract][Full Text] [Related]
15. Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling.
Compton SJ; Sandhu S; Wijesuriya SJ; Hollenberg MD
Biochem J; 2002 Dec; 368(Pt 2):495-505. PubMed ID: 12171601
[TBL] [Abstract][Full Text] [Related]
16. Proteolysis of the carboxyl-terminal GPI signal independent of GPI modification as a mechanism for selective protein secretion.
Wang J; Shen F; Yan W; Wu M; Ratnam M
Biochemistry; 1997 Nov; 36(47):14583-92. PubMed ID: 9398177
[TBL] [Abstract][Full Text] [Related]
17. Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells.
Becker S; Klenk HD; Mühlberger E
Virology; 1996 Nov; 225(1):145-55. PubMed ID: 8918541
[TBL] [Abstract][Full Text] [Related]
18. Intracellular cAMP assay and Eu-GTP-γS binding studies of chimeric opioid peptide YFa.
Kumar K; Kumar S; Kurupati RK; Seth MK; Mohan A; Hussain ME; Pasha S
Eur J Pharmacol; 2011 Jan; 650(1):28-33. PubMed ID: 20887721
[TBL] [Abstract][Full Text] [Related]
19. N-linked deglycosylated melanopsin retains its responsiveness to light.
Fahrenkrug J; Falktoft B; Georg B; Rask L
Biochemistry; 2009 Jun; 48(23):5142-8. PubMed ID: 19413349
[TBL] [Abstract][Full Text] [Related]
20. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.
Lublin DM; Krsek-Staples J; Pangburn MK; Atkinson JP
J Immunol; 1986 Sep; 137(5):1629-35. PubMed ID: 2427577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
